Kromek Group plc (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, is pleased to announce that it has secured an initial order for its CZT-based detector modules from a new OEM customer, which is an established player in the medical imaging sector in Asia. The contract consists of several elements worth a total of $1.425m and is in one of the Group’s key target markets of single photon emission computed tomography (“SPECT”).
The order is for the Group’s CZT-based detector modules, to be used in the customer’s next generation SPECT systems in niche applications. Delivery and revenue recognition will be in the current financial year.
Arnab Basu, CEO of Kromek Group, said: “This order, from a new OEM customer, is another demonstration of the robust demand for our innovative CZT-based medical imaging solutions in SPECT applications. This order from a new customer in Asia underscores the requirement of CZT-based detectors due to demand globally for early diagnosis of critical illnesses leading to better patient outcomes. This initial order improves the Group’s visibility over full year revenues, and as such the Board is confident in delivering further significant growth in the year ending 30 April 2024.”